Trial Profile
A study on the tissue responsiveness to short term exogenous growth hormone in children with idiopathic short stature in relation to their response to long-term treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jan 2021
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Short stature
- Focus Therapeutic Use
- Sponsors Pfizer
- 06 Jan 2009 New trial record.